Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 96
Titolo Data di pubblicazione Autori Tipo File Abstract
Immunophenotype and function of CD38-expressing CD4+ and CD8+ T cells in HIV-infected patients undergoing suppressive combination antiretroviral therapy 2015 E.S. CannizzoG.M. BellistrìC. TincatiN. IannottiA. D'Arminio MonforteG. Marchetti + Article (author) -
T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside retrotranscriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo study 2016 C. TincatiA. SavoldiE.S. CannizzoG.M. BellistrìG. Marchetti + Article (author) -
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 2016 M. GalliA. D'Arminio MonforteA. GoriC. F. PernoC. BalottaG. MarchettiS. RusconiC. Tincati + Article (author) -
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 2016 A. GoriA. D'Arminio MonforteM. GalliC. F. PernoC. BalottaA. BanderaG. MarchettiS. RusconiC. Tincati + Article (author) -
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives : Data from the ICONA cohort 2016 S. RusconiA. d'Arminio MonforteM. GalliC. F. PernoC. BalottaA. GoriG. MarchettiC. Tincati + Article (author) -
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection 2016 C. TincatiG. Marchetti + Article (author) -
Impaired gut junctional complexes feature late-treated individuals with suboptimal CD4+ T-cell recovery upon virologically suppressive combination antiretroviral therapy 2016 C. TincatiE. MerliniP. BraidottiG. AnconaD. TosiE. BorghiA. BarassiG. BulfamanteA. D'Arminio MonforteG. Marchetti + Article (author) -
Atazanavir/ritonavir monotherapy : 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 2016 S. RusconiC. TincatiE. MerliniM. GalliM. Franzetti + Article (author) -
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 2016 A. D'Arminio MonforteS. RusconiM. GalliC. F. PernoC. BalottaA. BanderaA. GoriG. MarchettiC. Tincati + Article (author) -
Cell-Mediated Immunity in HIV-Infected Males With Human Papillomavirus-Related Anal Dysplastic Lesions 2016 C. TincatiV. RainoneL. ComiA. PandolfoG.M. BellistrìM. RovatiA. D'Arminio MonforteD. TrabattoniG. Marchetti + Article (author) -
Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy 2016 E. MerliniC. TincatiM. BiasinI. SaulleF. A. CazzanigaA. d'Arminio MonforteM. ClericiGC. Marchetti . + Article (author) -
Clinical and viro-immunological correlates of HIV associated neurocognitive disorders (HAND) in a cohort of antiretroviral-naïve HIV-infected patients 2017 F. BaiF. IannuzziE. MerliniL. BorghiC. TincatiA. D'Arminio MonforteG. Marchetti + Article (author) -
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 2017 A. GoriA. d'Arminio MonforteM. GalliC. F. PernoC. BalottaA. BanderaG. MarchettiS. RusconiR. PioliniL. CarenziC. Tincati + Article (author) -
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 2017 S. RusconiA. D’Arminio MonforteM. GalliC. F. PernoC. BalottaA. BanderaG. MarchettiC. TincatiA. Gori + Article (author) -
The fecal microbiome directly drives immune activation in HIV infection 2018 Tincati, CamillaAncona, GiuseppeMarchetti, Giulia Article (author) -
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 2018 Alteri, ClaudiaAndreoni, M.Perno, C. F.D'Arminio Monforte, A.Lazzarin, A.Marchetti, G. C.Balotta, C.Bandera, A.Gori, A.Lapadula, G.Rusconi, S.Tincati, C. + Article (author) -
Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature 2018 C. TincatiE. MerliniA. d'Arminio MonforteG. Marchetti Article (author) -
Immune activation, inflammation and HIV DNA after 96-weeks of ATV/r monotherapy : a MODAt substudy 2018 Merlini, EstherTincati, CamillaCannizzo, Elvira SAncona, GiuseppeMonforte, Antonella d'ArminioMarchetti, Giulia + Article (author) -
Unconventional T cells in chronic hepatitis B patients on long-term suppressive therapy with tenofovir followed by a Peg-IFN add-on strategy: A randomized study 2018 C. TincatiF. BindaP. RonziS. AntinoriA. d'Arminio MonforteG. MarchettiCANNIZZO, ELVIRA STEFANIA + Article (author) -
Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen : Results from an Observational Cohort Study 2019 Cazzaniga F. A.Magnani M.Ancona G.Tincati C.d'Arminio Monforte A.Marchetti G. + Article (author) -
Mostrati risultati da 41 a 60 di 96
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile